Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Eli Lilly
Eli Lilly
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
Trading Desk
November 19, 2025
Health
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
By
Investment Desk
November 6, 2025
Health
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
By
Matty Merritt
and
Morning Brew
October 31, 2025
Eli Lilly (LLY) Q3 2025 Earnings Call Transcript
By
Industry Analyst
October 30, 2025
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript
By
Digital Assets Editor
August 7, 2025
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By
Eric Pfanner
and
Bloomberg
May 16, 2025
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By
Jonel Aleccia
and
The Associated Press
May 12, 2025
Eli Lilly (LLY) Q1 2025 Earnings Call Transcript
By
Contributing Writer
May 1, 2025
Politics
Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By
Research Team
April 30, 2025
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By
Marthe Fourcade
and
Bloomberg
April 22, 2025
Retail
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
By
Paula Doenecke
,
Naomi Kresge
and
Bloomberg
March 12, 2025
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By
Contributing Writer
March 4, 2025
Finance
Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By
Madison Muller
and
Bloomberg
February 26, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By
Market Analyst
February 19, 2025
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Senior Editor
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Blockchain Reporter
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Industry Analyst